| Financial Year |
March 31 2023 |
| Monetary Funds |
622,976,359.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
324,833,730.73 |
| Accounts Receivable |
1,851,067,253.70 |
| Advances to Suppliers |
142,616,360.71 |
| Other Receivables |
69,596,991.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,831,672,135.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,935,251.27 |
| Total Current Assets |
5,381,815,870.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,626,130.61 |
| Investment Properties |
-- |
| Fixed Assetes |
1,254,582,706.92 |
| Under-construction Projects |
369,527,083.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
240,059,440.86 |
| R&D expenses |
-- |
| Goodwill |
239,707,422.33 |
| Long-Term Deferred and Prepaid Expenses |
2,321,619.38 |
| Deferred Income Tax Assets |
94,328,302.41 |
| Other Non-Current Assets |
150,137,200.38 |
| Sub-Total of Non-Current Assets |
2,753,620,979.60 |
| Total Assets |
8,135,436,849.66 |
| Short-Term Loans |
199,510,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
954,670,616.32 |
| Accounts Payable |
1,296,312,177.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
52,842,102.27 |
| Taxes Payable |
46,769,770.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
118,716,566.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
54,874,340.08 |
| Other Current Liabilities |
118,461,169.09 |
| Sub-Total of Current Liabilities |
2,891,841,262.01 |
| Long-term Loans |
1,178,885,958.75 |
| Bonds Payable |
614,210,749.47 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,721,877.20 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,848,722,960.16 |
| Total Liabilities |
4,740,564,222.17 |
| Paid-In Capital(Or Share Stock) |
1,010,368,522.00 |
| Capital Surplus |
825,546,513.96 |
| Surplus Reserve |
190,564,812.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,195,076,301.28 |
| Minority Stockholder's Interest |
134,969,722.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,259,902,904.98 |
| Owner's Equity（Stockholder's Equity） |
3,394,872,627.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,135,436,849.66 |
